Law360, New York (October 30, 2009) -- Merck & Co.’s proposed $41.1 billion acquisition of Schering-Plough Corp. has gained approval from U.S. antitrust regulators on the condition that both companies shed certain assets.
The Federal Trade Commission on Thursday gave the deal the green light as long as Merck sells its stake in Merial Ltd., an animal health joint venture with Paris-based Sanofi-Aventis,...
